Clinical Trial

Pharmacokinetic Evaluation of Anrikefon Injection in the Geriatric Population With the Management of Acute Pain Following Abdominal Laparoscopy

Study acronym: PAGAP1
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 21, 2026 (before its estimated January 22, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study used a single-center, single-arm, pharmacokinetic ( PK ) study design. Thirty subjects who met the inclusion criteria were stratified according to age, including 15 in each age group of 65-74 years old and ≥ 75 years old. The patients were treated with a unified anesthesia method during abdominal endoscopic surgery. Anrecofin injection 1.0 μg / kg was injected for the first time within 15 min, and then once again at 8 h and 16 h. And received 6 pain assessments, 1 satisfaction score and 1 telephone follow-up. In this study, 10 blood samples were collected and analyzed.
Protocol Amendment History 1 change
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
Trial Details
NCT Number NCT07353983
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions Postoperative Pain
Enrollment 30 participants
Start Date 2026-01-01
Primary Completion 2026-01-22 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-21